Back

FARN

0.00%
NEUTRAL

Faron Pharmaceuticals to Publish 2024 Financial Results and Annual Report

Why we think this is neutral

The RNS is a standard regulatory announcement about the upcoming release of Faron Pharmaceuticals' financial results and annual report. While it provides transparency on the company's reporting timeline, there are no material updates or financial information included in the current announcement. The market impact is expected to be limited until the actual results are published.

Key Points

  • Faron Pharmaceuticals to publish 2024 financial results and annual report on February 27, 2025
  • Webcast scheduled on the same day for analysts, investors and media

Summary

The pharmaceutical company will publish its 2024 financial results and annual report on February 27, 2025, with a webcast for analysts and investors.

Faron Pharmaceuticals (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company, will publish its Financial Statement Release 2024 and Annual Report 2024 on Thursday, 27 February 2025. The company will also host a webcast on the same day for analysts, investors and media to discuss the results.

Key Dates

February 27, 2025
Faron Pharmaceuticals to publish 2024 financial results and annual report
GENERAL UPDATE